I'm not clued up on the mechanics or logistics of the pill manufacturing process. However if this Leiden data does confirm that MPL is a "remarkable" treatment for COVID-19, could there be a possibility that the tablet process could be expedited sooner?
After all the vaccines happened at record pace. I'm aware of the multitude of funding they received, but could third party funding be directed towards MPL if it's shown to have great efficacy in being a treatment and / or prophylactic?
Wonder if anyone could offer more insight into this?
WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?, page-3
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |